Physician profile
John Gordon Mcdaniel
NPI 1073580445
$798.65
in general payments reported to CMS, 2019-2025
6 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.54 · 2020: $81.22 · 2021: $71.46 · 2022: $70.53 · 2023: $254 · 2024: $79.61 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493 · Entertainment: $23.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.60 |
| Entertainment | $23.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $410.57 | 2022-2025 | Infuse, Infuse Multifocal, Biotrue One Day |
| Johnson & Johnson Vision Care, INC. | $172.24 | 2021-2024 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $158.20 | 2019-2021 | |
| Optos, INC. | $23.30 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.83 | 2019 | |
| Biotissue Holdings INC. | $16.51 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.